Advanced Solid Tumor Clinical Trials in Indianapolis, Indiana

4 studies are recruiting for advanced solid tumor in Indianapolis, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including urothelial cancer. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    IU Simon Cancer Center, Indianapolis, Indiana
    Locations
    39 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06465069 on ClinicalTrials.gov

  2. A Study of IDP-001 in Advanced or Metastatic Solid Tumors

    This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutan…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Community Cancer Center North, Indianapolis, Indiana
    Locations
    6 in total
    Run by
    InduPro, Inc.

    See if you can join NCT07602842 on ClinicalTrials.gov

  3. A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

    This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Community Health Network, Indianapolis, Indiana
    Locations
    14 in total
    Run by
    Volastra Therapeutics, Inc.

    See if you can join NCT05902988 on ClinicalTrials.gov

  4. A Study of LM-24C5 For Advanced Solid Tumors

    To assess the safety and tolerability, obtain the recommended phase 2 dose (RP2D)/optimal biologic dose (OBD) and/or Maximum Tolerated Dose (MTD) for LM-24C5 in subjects with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Indiana University Melvan and Bren Simon Cancer Center, Indianapolis, Indiana
    Locations
    6 in total
    Run by
    LaNova Medicines Limited

    See if you can join NCT06187402 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.